The Hadri Lab of Cardiopulmonary diseases and Gene Transfer 

Our specific research areas are focused on vascular physiopathology and somatic gene transfer for treating progressive coronary artery disease, pulmonary arterial hypertension (PAH), and heart failure. Despite extensive research efforts in experimental and clinical studies, lung diseases and heart failure remain an increasing cause of morbidity and mortality. There is a compelling need to develop a more effective and reliable therapeutic strategy.